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Abstract
Neuroﬁlament (NFL) proteins have recently been found to play unique roles in synapses. NFL is known to interact with
the GluN1 subunit of N-methyl-D-aspartic acid (NMDAR) and be reduced in schizophrenia though functional
consequences are unknown. Here we investigated whether the interaction of NFL with GluN1 modulates synaptic
transmission and schizophrenia-associated behaviors. The interaction of NFL with GluN1 was assessed by means of
molecular, pharmacological, electrophysiological, magnetic resonance spectroscopy (MRS), and schizophrenia-
associated behavior analyses. NFL deﬁcits cause an NMDAR hypofunction phenotype including abnormal
hippocampal function, as seen in schizophrenia. NFL−/− deletion in mice reduces dendritic spines and GluN1 protein
levels, elevates ubiquitin-dependent turnover of GluN1 and hippocampal glutamate measured by MRS, and depresses
hippocampal long-term potentiation. NMDAR-related behaviors are also impaired, including pup retrieval, spatial and
social memory, prepulse inhibition, night-time activity, and response to NMDAR antagonist, whereas motor deﬁcits are
minimal. Importantly, partially lowering NFL in NFL+/−mice to levels seen regionally in schizophrenia, induced similar
but milder NMDAR-related synaptic and behavioral deﬁcits. Our ﬁndings support an emerging view that central
nervous system neuroﬁlament subunits including NFL in the present report, serve distinctive, critical roles in synapses
relevant to neuropsychiatric diseases.
Introduction
Neuroﬁlaments (NF), unlike intermediate ﬁlaments of
non-neuronal cells, are composed of four distinct sub-
units under complex regulation by phosphorylation1. The
purpose of this added complexity of neuronal inter-
mediate ﬁlaments has, until recently, been a puzzle. As
linear heteropolymers, neuroﬁlaments support the radial
expansion of large myelinated axons. Because rare
mutations of NFL (neuroﬁlament light subunit, NEFL)
cause a subtype of the peripheral axonopathy, Charcot-
Marie-Tooth disease2–4, attention has previously focused
mainly on roles of NF proteins in maintaining the ela-
borate axonal NF lattice of large caliber peripheral axons.
In the central nervous system (CNS), however, NFs play a
minor role in axon caliber expansion5,6 and recent evi-
dence has shown that NF proteins form distinct proto-
ﬁlamentous assemblies within synaptic spines where the
individual NF subunits differentially interact with speciﬁc
neurotransmitter receptors and modulate their activity7.
Dendritic spines are believed to be an anatomical sub-
strate for memory storage and synaptic transmission8,9
and a key feature of these spines is the postsynaptic
density (PSD), which is critical for receptor stability and
activity. The PSD is anchored and its functions are
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regulated by an actin-based cytoskeletal scaffold10 com-
posed of proteins that interact directly with receptors,
such as N-methyl-D-aspartic acid (NMDAR)11. Notably,
mutations or deletions of many of the genes encoding
proteins comprising the synaptic scaffold are believed to
cause neuropsychiatric disorders, including schizo-
phrenia, autism, and mental retardation (Supplementary
Table S1). NF proteins have rarely been considered in
relation to the synaptic scaffold, however, the evidence for
a signiﬁcant synaptic location of NF proteins and a wealth
of recent proteomic data led us to propose that NFP is a
core synaptic scaffold component6,7 and that NFL, which
is known to interact with the GluN1 subunit of
NMDAR12, may be essential for the proper functioning of
this receptor. Supporting this possibility, an NFL inter-
actome constructed from published data (Supplementary
Figure S1) reveals direct interactions of NFL with many of
the known postsynaptic scaffold proteins. Notably, a high
proportion of these proteins are known to be altered in
schizophrenia and other neuropsychiatric diseases (Sup-
plementary Table S1).
The NMDAR, composed of four subunits including the
essential GluN1 subunit13,14, is located on the post-
synaptic membrane where it contributes to the expression
of long-term potentiation (LTP) and synaptic plasticity
thought to underlie learning and memory15. NMDAR
hypofunction is believed to be involved in the pathophy-
siology of schizophrenia and genetic, biochemical, and
pharmacological evidence documents reduced expression
of particular subunits of the receptor, including GluN1, in
the brains of individuals with schizophrenia16–21. Mice
expressing reduced levels of the GluN1 subunit have been
proposed as an animal model of schizophrenia22.
NMDAR is also a major component of the PSD complex
and its GluN1 subunit interacts with NFL in vitro and in
non-neuronal cells transfected with NFL protein12.
Moreover, like the GluN1 deﬁcit in schizophrenia, sub-
stantially reduced levels of NFL are a remarkably con-
sistent ﬁnding in affected regions of schizophrenic brain
(Supplementary Table S2) although the functional sig-
niﬁcance of these deﬁcits is unclear. Also, although we
previously showed that the NFL subunit is an integral
component of synapses, its functions at this site have not
been previously addressed.
In the present report, we establish novel synaptic roles
for the NFL subunit in maintaining spine morphology,
stabilizing GluN1 levels, and modulating NMDAR func-
tion and related behavior. NFL gene deletion in mice
lowered numbers and lengths of dendritic spines,
depressed hippocampal long-term potentiation induction,
and selectively depressed NMDAR–GluN1 protein levels
and NMDAR-related behaviors while adaptively raising
hippocampal glutamate levels. Importantly, we observed a
similar range of NMDAR-related synaptic and behavioral
deﬁcits, albeit milder than in NFL-null mice, in NFL+/−
mice, in which brain NFL levels were lowered 40–50%, a
reduction within a range of NFL deﬁcits seen in brain
regions implicated in schizophrenia23 (Supplementary
Table S2). Our ﬁndings reinforce an emerging concept
that CNS NFL serve distinctive roles in synaptic trans-
mission and behaviors related to the modulation of spe-
ciﬁc neurotransmitter receptors and we identify speciﬁc
roles of the NFL subunit in NMDAR function.
Materials and methods
Generation of mutant animals, drugs, and antibodies
Please see Supplementary Information.
Analytical methods
Our published methods were used for all the proce-
dures. Please see Supplementary Information.
Results
NFL is essential for the maintenance of dendritic spine
structure and function
Immuno-electron microscopy (EM) studies conﬁrmed
ultrastructural colocalization of NFL and NFH on the
same ﬁlament within dendrites (Fig. 1a, b) and post-
synaptic terminals (Fig. 1c, d). Densitometric quantiﬁca-
tion of immunostained proteins revealed that levels of
NFL proteins in hippocampal homogenates and synap-
tosomes from NFL−/− mice were undetectable, as
expected (Fig. 1e). Levels of NFH were reduced to 22% of
normal wild-type levels. By contrast, synaptosomes in
these mice retained ~ 50% of normal levels of NFM and
80% of normal INA, reﬂecting their known close physical
and functional partnership24. Subunit stoichiometry in
NFL−/− hippocampus is comparable to previous analyses
of optic axons25. An earlier study reporting NFM and
NFH in NFL−/− mice to be only 5% of WT levels26 can
be explained by the fact that only phosphorylation-
dependent isoforms were used in this study, whereas we
used phosphorylation-independent anti-NFM and anti-
NFH antibodies, which detect the larger total populations
of each subunit.
We next used a rapid Golgi impregnation method to
examine the effects of NFL deletion on the dendritic
spines of hippocampal CA1 neurons (Fig. 1f, g). Spine
density on dendritic arbors of CA1 neurons were sig-
niﬁcantly reduced in NFL−/− mice compared with NFL
+/+ mice (p < 0.0001, n= 8) (Fig. 1h). Spine length was
also signiﬁcantly decreased (p < 0.001) (Fig. 1i). Similar
changes in spine density and spine length were seen in
dentate gyrus granule cells (Fig. 1j−l). In addition, path
lengths of dendrites were signiﬁcantly reduced in dentate
gyrus granule cells of NFL−/− mice (Supplementary
Table S3). NFL deletion had a greater effect on spines
(lowered 41% in spine density and 24% in spine length)
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(Fig. 1k, l) than on dendrites (lowered 13% in average
path) (Supplementary Table S3), further suggesting the
important structural role of NF proteins speciﬁcally
within synaptic spines. Given the changes in spine mor-
phology, we investigated whether or not NFL−/− mice
have LTP deﬁcits. Hippocampal basal synaptic neuro-
transmission and LTP in the Schaffer collateral pathway
of hippocampal slices were found signiﬁcantly impaired in
NFL−/− as compared with NFL+/+ mice (p < 0.001, n=
7) (Fig. 1m–o).
NFL is essential for maintenance of NMDAR stability and
activity at synapses
Immuno-EM studies with anti-GluN1 antibody revealed
reduced GluN1 immunoreactivity in hippocampal
synapses (Fig. 2a–c). [3H]MDL105,519 ligand binding to
Fig. 1 Reduced dendritic spine length and density and impaired CA1 LTP in the hippocampus of NFL−/− mice. Ultrastructural colocalization
of NFL (arrowheads) and NFH (arrows) on the same NF within dendrites a, b and postsynaptic terminals c, d by immunogold electron microscopy.
Dendrite boundaries and postsynaptic neuroﬁlaments are outlined to clearly indicate the morphology. PSD: postsynaptic density. Scale bars, 150 nm
in a; 30 nm in b; 40 nm in c, and d. Protein extracts prepared from total hippocampus homogenate and hippocampal synaptosomal fractions were
separated on an 8.5% SDS-polyacrylamide gel and transferred to nitrocellulose membrane. Membranes were blotted with different antibodies. NFL
were undetectable in NFL−/− mice e. NFH and alpha-internexin in NFL−/− mice were reduced to 22 and 82% of wild-type level, respectively, in
both total homogenate and synaptosomes. NFM was reduced to 50% in total homogenate and 47% of wild-type level in synaptosomes, respectively.
Data are expressed as Mean ± SEM, n= 6. H: homogenate; SS: synaptosomal fractions. Spine density was compared between NFL+/+ and NFL−/−.
Spine density is expressed as the number of spines per 10 microns of dendrite. f, g Spine density on CA1 pyramidal neurons was reduced on
dendrites in NFL−/− (p < 0.0001) h. Spine length is expressed as microns per spine. Spine length on CA1 pyramidal neurons was also reduced on
dendrites in NFL−/− (p < 0.001) i. Data are expressed as mean ± SEM, n= 8. Arrows point to a representative spine in each genotype. Scale bar: 1 µm.
Reduction of dendrite length (Supplementary Table S3), dendritic spine density j, k and spine length l in dentate gyrus granule cells of NFL−/−mice.
m A summary graph showing the ﬁeld I/O relationship for NFL+/+ (green) and NFL−/− (red) mice. n A time course of the average of the fEPSP
slopes from slices obtained from NFL+/+ and NFL−/− mice. The fEPSP slopes were normalized to the average value during the 10 min prior to
stimulation in each experiment. An arrow shows the time of tetanic stimulation (four pulses at 100 Hz with bursts repeated at 5 Hz, and each tetanus
including three 10-burst trains separated by 15 s). o A combined plot of the averages of fEPSP slopes at several time points. Each point is the mean ±
SEM (n= 7 mice per group, 14–20 slices per group). Two-way ANOVA with Bonferroni’s post hoc test; p < 0.001. *: p < 0.05; **: p < 0.01; ***: p < 0.001
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GluN1 was also signiﬁcantly reduced in the hippocampal
homogenates of NFL−/− as compared with NFL+/+
mice (Fig. 2d). Western blot studies showed that
GluN1 subunit levels in hippocampal synaptosomes from
NFL−/− mice were also substantially reduced (lowered
65%, p < 0.001) (Fig. 2e). Similar results were also
observed in triple knockout mice lacking alpha-inter-
nexin, NFH, and NFL mice (Supplementary Figure S2).
Fig. 2 Reduced GluN1 expression and increased glutamate and glutamine levels in hippocampal 1H MRS metabolite measurements of NFL
−/− mice as compared with NFL+/+ controls. In the absence of NFL, the level of NMDAR–GluN1 subunit in hippocampus was signiﬁcantly
decreased by immuno-EM with anti-GluN1 monoclonal antibody a–c. Scale bar in a, b: 150 nm. *: p < 0.05; ***: p < 0.001. Reduced level of GluN1 was
conﬁrmed by decreased binding of GluN1 subunit of NMDAR ligand [3H]MDL105,519 in the hippocampus of NFL−/− mice. P < 0.05, n= 8 d.
Western blot with anti-GluN1 antibody also conﬁrmed a reduced level of synaptosomal GluN1 from hippocampi, whereas the level of NR2b subunit
was not signiﬁcantly affected e. f Increased K48-linkage speciﬁc ubiquitin signals in GluN1-rich postsynaptic membrane fractions isolated from
hippocampal synaptosomes of NFL−/− mice. GluN1-rich postsynaptic membrane fractions prepared from hippocampal synaptosomes were
separated on an 8.5% SDS-polyacrylamide gel and transferred to nitrocellulose membrane. Membranes were blotted with K48-linkage-speciﬁc
ubiquitin antibody and ATPase antibody. Densitometric quantiﬁcation of immunostained proteins showed that K48-linkage-speciﬁc ubiquitin signals
normalized to ATPase are signiﬁcantly increased in the absence of NFL (p < 0.01, n= 8–12), whereas K63-linkage-speciﬁc ubiquitin signals was not
signiﬁcantly affected. g, h Co-immunoprecipitation of NFL with GluN1 from hippocampal synaptosomal preparations. GluN1-NT, GluN1 N-terminus
antibody; GluN1-CT, GluN1 C-terminus antibody; B, bound; UB, unbound. *: p < 0.05; **: p < 0.01. i The VOI size was 5 µl (1 × 2 × 2.5 mm3) within
hippocampus overlaid in red on the coronal anatomical scan. j Representative LCModel output spectrum from the hippocampus of a single NFL−/−
mouse showing major labeled metabolites (N-Acetyl aspartate (NAA), glutamate (Glu), glutamine (Gln), total creatine (tCr), and total choline (tCho)).
The black line represents the raw data and the red line represents the ﬁt. The plot at the top shows the difference between plots. A good ﬁt should
look like random noise with oscillations about zero. k 1H MRS glutamate concentration in NFL−/− versus NFL+/+mice in the hippocampus showed
a signiﬁcant difference. l, m 1H MRS glutamine and glutamate plus glutamine concentrations in NFL−/− versus NFL+/+ mice in the hippocampus
also showed signiﬁcant differences. n 1H MRS NAA concentration in NFL−/− versus NFL+/+ mice in the hippocampus did not show a signiﬁcant
difference. All data are presented as mean ± SEM (n= 16). *: p < 0.05; **: p < 0.01. Both female and male NFL−/− mice showed similar direction of
change in glutamate and glutamine levels as compared with NFL+/+ mice (Supplementary Figure S3) and no signiﬁcant differences of glutamate
levels were observed between gender in NFL+/+ and NFL−/− mice (Supplementary Figure S4)
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Densitometric quantiﬁcation of immunostained proteins
revealed that proteasome-degradation-related K48-
linkage speciﬁc ubiquitin signals normalized to ATPase
signal, a marker of plasma membrane27, are signiﬁcantly
increased in the absence of NFL (p < 0.05, mean ± SEM, n
= 8–12) (Fig. 2f), whereas non-proteasome-degradation-
related k63-linkage speciﬁc ubiquitin signals were not
signiﬁcantly altered28. In synaptosomal fractions, we also
showed co-immunoprecipitation of GluN1 with NFL (Fig.
2g) and NFL with GluN1 (Fig. 2h), further substantiating
in vivo interaction between GluN1 and NFL.
Increased glutamate in the hippocampus of NFL−/−
measured by 1H MRS
To determine whether lack of NFL affects glutamate
level in hippocampus, we used in vivo magnetic resonance
spectroscopy to measure regional content of relevant
amino acids and metabolites in brain. The levels of Glu (p
< 0.05, n= 16) and Gln (p < 0.01) concentrations were
signiﬁcantly increased in the hippocampal region of NFL
−/− as compared with NFL mice (Fig. 2i–m). Hippo-
campal N-acetyl aspartate (NAA) levels in NFL−/− mice
did not differ signiﬁcantly from NFL+/+ controls (Fig.
2n).
NFL deletion causes diverse behavioral deﬁcits related to
NMDAR hypofunction
To rule out the inﬂuence of a possible motor deﬁcit on
NMDAR-related behavior, we ﬁrst performed grip
strength and amphetamine-stimulated motor activity with
NFL−/− mice, which showed no signiﬁcant impairment
of motor capability in NFL−/− mice as compared with
NFL+/+ controls (Fig. 3a, b). By contrast, NFL−/− mice
displayed markedly reduced night-time locomotor activity
at 9 pm as compared with NFL+/+ controls (P < 0.001)
(Fig. 3c). To implicate NMDAR in this locomotor deﬁcit,
we administered phencyclidine (PCP), an NMDAR
antagonist that induces motor stimulant effects29. The
motor stimulant effect of PCP was markedly decreased in
NFL−/− mice (p < 0.0001) (Fig. 3d), supporting the
NMDAR relationship to locomotor deﬁcits. We also
found that a 6 dB prepulse of sound induced signiﬁcantly
greater inhibition of the startle reﬂex in NFL+/+ mice
than in NFL−/− animals (Fig. 3e), indicating that NFL
deletion leads to a deﬁcit in PPI.
Pup retrieval is a social interaction test and a deﬁcit in
pup retrieval in mice has been used as an indicator of
abnormal social interaction30–32. A pup retrieval test with
NFL−/− mice showed that 9 out of 10 NFL+/+ mice
ﬁnished the pup retrieval task within 10 min, whereas only
four out of 10 NFL−/− mice did (Fig. 3f). Statistical
analyses established a signiﬁcant deﬁcit in this innate
maternal behavior in NFL−/− mice (χ2-test, n= 10, p <
0.05). NFL+/+ control mice displayed normal social
memory, as demonstrated by a marked habituation
(decreased exploration) during the ﬁrst four trials and a
striking dishabituation (increased exploration) upon the
presentation of a novel animal on the 5th trial (Fig. 3g, h).
By contrast, NFL−/− mice showed no signiﬁcant habi-
tuation during the four exposures to the stimulus mouse
or dishabituation to the novel stimulus mouse indicating a
marked deﬁcit in social interaction.
Object-placement task is hippocampus-dependent spa-
tial memory test and glutamatergic transmission
abnormalities can cause behavioral deﬁcit in object-
placement memory33,34. Object placement was assessed
in NFL−/− mice with one-trial object-place recognition
task in which the mice were allowed to investigate two
objects for 5 min during a training session. After 4 h delay,
a 5-min test trial was administered in which the mice were
allowed to investigate the same two objects, but with one
of the objects moved to a novel location. As expected, the
NFL+/+ mice investigated the moved object signiﬁcantly
more frequently than the stationary object (p < 0.01) (Fig.
3i). By contrast, NFL−/− mice did not show a preference
for the moved object, suggesting they have impaired
spatial memory of the training conﬁguration. NFL−/−
and NFL+/+ mice showed similar numbers of explora-
tions for both objects (Fig. 3j). We also assessed
hippocampus-dependent memory with an object recog-
nition task. This test is identical to the object-placement
test, except that a novel object is substituted in the same
location for one of the training objects during the test
trials. Again, NFL+/+ mice showed a signiﬁcant pre-
ference for the novel object, whereas NFL−/− did not (p
< 0.01) (Fig. 3k). There was no signiﬁcant difference
between the number of explorations for both objects by
NFL−/− and NFL+/+ mice (Fig. 3l).
Partial NFL depletion in NFL+/− mice induces NMDAR-
related deﬁcits of synaptic plasticity and behavior
To determine the effects of a less-severe loss of NFL as
might be associated with disease, we investigated certain
of the above studied parameters in NFL+/− as compared
with wild-type control mice. Immunoblot analyses of NF
subunit protein levels revealed that NFP stoichiometry
changed in different ways in hippocampal homogenate
and synaptosomes from NFL+/− mice (Fig. 4a). Subunit
levels were altered more in synaptosomes than in
homogenates. NFL and NFM were reduced to half of the
WT level (p < 0.01): NFH and alpha-internexin were less
affected (63% and 77% of wild-type, respectively) than
NFL and NFM. Previous studies also showed that the level
of NFL protein decreased by 40% in the brain of NFL+/−
mice35 and the levels of NFH, NFM, and INA in the
cortex vary with age in the absence of NFL36. This extent
of NF subunit change in synapses was associated, how-
ever, with signiﬁcant synaptic dysfunction.
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NFL+/− mice exhibited signiﬁcantly reduced spine
density (p < 0.001, n= 8) on dendritic arbors of CA1
neurons although spine lengths were unaltered (Fig. 4b).
Similar effects of partial deletion of NFL were seen not
only on spine density (p < 0.01) of dentate gyrus granule
cells (Supplementary Figure S6a, b) but also with reduced
spine length (p < 0.001) (Supplementary Figure S6c),
indicating regional difference. Moreover, hippocampal
basal synaptic neurotransmission and LTP in the Schaffer
collateral pathway of hippocampal slices were signiﬁcantly
Fig. 3 NFL−/−mice have NMDAR-related behavioral deﬁcits and deﬁcits in memory. There were no signiﬁcant differences in grip strength test
(front and back legs) a and amphetamine-stimulated locomotor activity between NFL+/+ and NFL−/− mice b. c Night-time locomotor activity was
signiﬁcantly reduced in NFL−/− mice (p < 0.001). All data are presented as mean ± SEM (n= 8). d NFL−/− mice have reduced stimulant effect of
phencyclidine (PCP). Motor stimulant effect of NMDAR antagonist PCP was signiﬁcantly decreased in NFL−/− mice (P < 0.0001). All data are
presented as mean ± SEM (n= 11–12). e NFL−/− mice showed reduced prepulse inhibition (p < 0.05). All data are presented as mean ± SEM (n= 8).
**: p < 0.01. f Pup retrieval deﬁcit. Schematic representations of the pup retrieval test in a mated pair isolated in an old cage. After cohabitating with
their pups as a family unit, the dams were separated from the pups for 10 min and then reunited with ﬁve pups. Subsequent pup retrieval behavior
was then observed and the number of dams showing retrieval was scored and expressed as a percentage. NFL−/− mice showed a signiﬁcant deﬁcit
in pup retrieval as compared with NFL+/+ and NFL+/− mice (χ2 test, n= 10, p < 0.05). g, h Social interaction deﬁcits in NFL−/− mice based on the
ﬁve-trial social memory test. NFL+/+ mice displaying normal social recognition showed the standard pattern of high socialization time (trial 1)
followed by decreased socialization time (trials 2–4; P= 0.0004 at trial 3 and P < 0.0001 at trial 4) and increased socialization time with a novel mouse
(trial 5, P < 0.0001). NFL−/− mice displaying social recognition defects showed a disrupted pattern of habituation to the same mouse (trials 1–4) and
dishabituation to a novel mouse (trial 5, p > 0.05). Both female and male NFL−/− mice showed similar direction of change in social memory as
compared with NFL+/+ mice. All data are presented as mean ± SEM (n= 16). i, j NFL−/− mice showed a deﬁcit in hippocampus-dependent spatial
memory as measured by object placement. NFL−/− mice did not show increased preference for the moved object in a place preference designed
to measure hippocampus-dependent spatial memory (p > 0.05), whereas NFL+/+ mice did prefer the moved object as measured by a signiﬁcant
increase in the number of investigations of the moved object (n= 16, p < 0.01). NFL−/− mice showed similar number of investigations for both
objects as compared with NFL+/+ mice (p > 0.05). All data are presented as mean ± SEM (n= 16–17). k, l NFL−/− mice did not show increased
preference for the novel object in a novel preference designed to measure hippocampus-independent visual memory (p > 0.05), whereas NFL+/+
mice did prefer the novel object as measured by a signiﬁcant increase in the number of investigations of the novel object (p < 0.01). NFL−/− mice
showed similar number of investigations for both objects as compared with NFL+/+ mice (p > 0.05). All data are presented as mean ± SEM (n=
16–17). **: p < 0.01; ***: p < 0.001. Both female and male NFL−/− mice showed similar direction of change in both object placement and object
recognition as compared with NFL+/+ mice (Supplementary Figure S5)
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impaired in NFL+/− as compared with NFL+/+ mice (p
< 0.001, n= 5) (Fig. 4c–e). GluN1 levels in the hippo-
campus of NFL+/− mice determined by ligand-binding
assay using [3H]MDL105,519 were signiﬁcantly reduced
(Fig. 4f). NFL+/− mice showed a signiﬁcantly diminished
night-time locomotor activity at 9 pm as compared with
NFL+/+ controls (p < 0.001, n= 8) (Fig. 4i). The motor
stimulant effect of PCP was also signiﬁcantly decreased in
NFL+/− mice (p < 0.05, n= 9) (Fig. 4j). We also found
that a 3 dB prepulse of sound induced a signiﬁcantly
greater inhibition of the startle reﬂex in NFL+/+ mice
than in NFL+/− animals (n= 24–26, p < 0.05) (Fig. 4k),
Fig. 4 NFL+/− mice showed NMDAR-related partial deﬁcits between NFL+/+ and NFL−/− mice. a Analysis of NF protein expression in NFL
+/+ and NFL+/− mice. Protein extracts prepared from total hippocampus homogenate and hippocampal synaptosomal fractions were separated
on an 8.5% SDS-polyacrylamide gel and transferred to nitrocellulose membrane. Membranes were blotted with different antibodies. Compared with
WT levels, NFL, and NFM in NFL+/− mice are lowered 31 and 24%, respectively, in total homogenate (p < 0.001) but to 50–51% of WT levels in
synaptosomes (p < 0.01). NFH and alpha-internexin are lowered 29% (p < 0.05) and 9%, respectively, in total homogenate and to 37% and 23%,
respectively, in synaptosomes. Data are expressed as Mean ± SEM, n= 6. H: homogenate; SS: synaptosomal fractions. b Reduced dendritic spine
density in the hippocampus of NFL+/− mice. Spine density on CA1 neurons was reduced on dendrites in NFL+/− mice (P < 0.01). All data are
presented as mean ± SEM (n= 8). Impaired CA1 LTP in NFL−/− mice. c A summary graph showing the ﬁeld I/O relationship for NFL+/+ (green) and
NFL+/− (red) mice. d A time course of the average of the fEPSP slopes from slices obtained from NFL+/+ and NFL+/− mice. e A combined plot of
the averages of fEPSP slopes at several time points. Each point is the mean ± SEM (n= 5 mice per group, 10 slices per group). Two-way ANOVA with
Bonferroni’s post hoc test; p < 0.001. f Reduced level of GluN1 was demonstrated by decreased binding of GluN1 subunit of NMDAR ligand [3H]
MDL105,519 in the hippocampus of NFL+/− mice. There were no signiﬁcant differences in amphetamine-stimulated locomotor activity g and grip
strength test (front and back legs) between NFL++ and NFL+/− mice h. i Night-time locomotor activity was signiﬁcantly reduced in NFL+/− mice
(p < 0.01). Data are presented as mean ± SEM (n= 8). j Motor stimulant effect of NMDAR antagonist PCP was partially reduced in NFL+/− mice (p <
0.05). Data are presented as mean ± SEM (n= 8). k NFL+/− mice showed reduced prepulse inhibition (p < 0.05). All data are presented as mean ±
SEM (n= 24–26). l Social interaction deﬁcits in NFL+/− mice based on the ﬁve-trial social memory test. NFL+/+ mice displaying normal social
recognition showed the standard pattern of high socialization time (trial 1) followed by decreased socialization time (trials 2–4; p < 0.05 at trial 3 and
p < 0.01 at trial 4) and increased socialization time with a novel mouse (trial 5, P < 0.01). NFL+/− mice displaying social recognition defects showed a
disrupted pattern of habituation to the same mouse (trials 1–4) and dishabituation to a novel mouse (trial 5, p > 0.05). All data are presented as mean
± SEM (n= 8). *: p < 0.05; **: p < 0.01; ***: p < 0.001
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indicating that NFL partial deletion could lead to deﬁcits
in PPI. NFL+/− mice also showed a signiﬁcant deﬁcit in
social interaction (p < 0.05, n= 8) (Fig. 4l). As shown in
Fig. 4g, h, there was no signiﬁcantly impaired motor
capability in NFL+/− mice as compared with NFL+/+
controls as measured by grip strength and amphetamine-
stimulated motor activity.
Discussion
In this report, we demonstrate that NFL is a critical
component of synaptic spines and is essential for main-
taining spine structural integrity and function. We present
multiple lines of evidence showing that NFL modulates
NMDAR level and function through a direct in vivo
interaction with the GluN1 subunit, which protects
against GluN1 ubiquitination and turnover. Finally, we
show that even partial reductions in NFL levels, con-
ceivably attainable in some neuropsychiatric states, have
substantial synaptic and behavioral effects related to
lowered GluN1 levels and diminished NMDAR activity.
NFL deletion is known to decrease axon caliber
expansion and dendritic growth of large motoneurons
during brain development26,37 and NFL’s role in large
myelinated peripheral axons has been a dominant focus of
most neuroﬁlament investigations. Consistent with these
ﬁndings, we also found signiﬁcantly reduced dendrite
length, reduced spine density and spine length in dentate
gyrus granule cells and reduced spine density and length
in CA1 neurons of the hippocampus in NFL−/− mice
even though neuroﬁlaments in CNS neurons contribute
minimally to axon caliber as demonstrated in our double
and triple NF subunit deletion mice5,6. Dendritic spine
pathology is known to be associated with various neu-
ropsychiatric disorders that are also associated with NF
protein alterations38–40 and our ﬁndings strongly suggest
that loss of NFL from synapses may contribute to the
spine instability and loss seen in some diseases. Notably,
there is reduced dendritic spine density on cerebral cor-
tical pyramidal neurons in schizophrenia41. In support, we
saw that even a partial reduction in NFL (40%), in the
range of losses seen in vulnerable brain regions in schi-
zophrenia, are associated with spine abnormalities.
We further showed that the spine alterations in NFL-
deleted mice are accompanied by a marked impairment in
basal synaptic transmission and LTP. For the ﬁrst time,
NFL−/− deletion in mice is shown to lower
NMDAR–GluN1 protein levels and suppress NMDAR
complex function while raising brain glutamate con-
centrations in hippocampus, presumably as a compensa-
tory response42–45. Loss of NFL impaired NMDAR
stability, synaptic signaling, and function in mediating
behaviors known to be related to activity of this receptor.
The selective decrease of GluN1 subunit associated with
NFL deletion is consistent with previous evidence that
exogenous NFL subunit co-expressed with GluN1 subunit
in HEK 293 cells increased GluN1 cell surface expres-
sion12 and prevented its ubiquitination in vitro46. In our
study, we demonstrated that K48-linkage-speciﬁc ubi-
quitin signals are signiﬁcantly increased in GluN1-rich
postsynaptic membranes from the hippocampi of NFL
−/− mice. This ﬁnding and the reduced levels of
GluN1 suggest that, when NFL interaction with the
receptor is lost, GluN1 degradation by the ubiquitin-
proteasome system is increased, consistent with evidence
that GluN1 is a substrate of the UPS46,47.
Using proton magnetic resonance spectroscopy (MRS),
a noninvasive method to measure neurotransmitter con-
centrations in vivo. we detected elevated glutamate and
glutamine concentrations in the hippocampus, of NFL
−/− mice as compared with NFL+/+ controls. Although
individual 1H-MRS glutamate studies in schizophrenia
have produced some inconsistent ﬁndings, a recent meta-
analysis of proton MRS studies demonstrated schizo-
phrenia is associated with elevations in glutamatergic
metabolites across several brain regions44. Increased glu-
tamate and glutamine concentrations in the hippocampus
of NFL−/− mice could be a result of decreased levels of
NMDAR and could reﬂect the attempt of the system to
compensate for postsynaptic glutamatergic hypofunction
due to increased GABA disinhibition45.
NFL−/− mice display a range of behavioral deﬁcits
associated with schizophrenia and in animal models of
NMDAR hypofunction48 or GluN1 reduction49,50,
including signiﬁcant deﬁcits of hippocampus-dependent
social memory34. Pup retrieval behavior, a measure of
hippocampus-dependent nonlearned innate behavior51,52
was markedly impaired. Also, object-placement and
object-recognition tasks, which are hippocampus-
dependent spatial memory tests34,53 were deﬁcient in
NFL−/− mice. Prepulse inhibition, a characteristic fea-
ture of patients with schizophrenia and certain other
psychiatric diseases, was also reduced in NFL−/− mice.
NFL−/− mice also have a reduction in night-time spon-
taneous locomotor activity that shows up most clearly at
peak time points, suggesting that NFL has effects on
locomotor systems that are not clearly a mimic of motor
or sleep abnormalities found in schizophrenia54–56.
Although early studies reported increased locomotor
activity in mice expressing 5% of normal levels of
GluN122, recent investigation showed that locomotor
activity in these mice is comparable to the locomotor
activity of wild-type littermates in a familiar environ-
ment57. In fact, locomotor activity is not directly corre-
lated to the levels of GluN1, as increased locomotor
activity has been reported to be associated with both
increase58 or decrease59 of GluN1 levels. PCP is often
used to model aspects of schizophrenia, inducing their
prominent psychotomimetic effects by blocking
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neurotransmission at NMDAR-type glutamate receptors
and inducing schizophrenia-related behaviors16,60–64. The
present results showing a lack of response to PCP-
induced locomotor activation in the NFL−/− mice fur-
ther suggest altered NMDAR-mediated mechanisms
although one might expect increased sensitivity to PCP-
induced locomotor effects in schizophrenic patients.
Our results generally parallel the deﬁcits reported for
GluN1 reduction models49,50. As NMDAR hypomorph
mice show up to 95% reduced expression of GluN122,50, a
reduction much greater than what has been shown in
postmortem studies of schizophrenia brains65,66, hetero-
zygous GluN1−/− mice exhibiting a 30% reduced
expression of GluN1 have been proposed to be more
disease relevant in schizophrenia studies50. A 36%
reduction of GluN1 protein was reported in postmortem
brain (dorsolateral prefrontal cortex) from people with
schizophrenia66. Although other studies reported incon-
sistent ﬁndings67,68, a recent meta-analysis of ﬁve studies
of GluN1 protein, consisting of 95 subjects with schizo-
phrenia and 95 controls, indicates a signiﬁcant decrease in
expression of GluN1 protein in schizophrenia subjects
relative to controls68. Consistent with these ﬁndings from
human studies, a 30% reduction of GluN1 protein in rat
hippocampus induced by GluN1-antisense treatment
produced deﬁcits of prepulse inhibition, a well-deﬁned
ﬁnding in schizophrenia49.
Modeling closely the NFL declines reported in affected
brain regions in schizophrenia, NFL+/−mice exhibiting a
40% reduction in NFL levels also have signiﬁcant
NMDAR-related deﬁcits. Levels of NFL protein are
decreased ~ 50% (statistically signiﬁcant) by western blot
in the dorsolateral prefrontal cortex and ~ 40% (not sig-
niﬁcant) in the anterior cingulate cortex from patients
with schizophrenia23. Although 15% increase of NFL
transcript was initially reported (these effects were across
the collapsed layers and none showed isolated signiﬁcant
changes in a speciﬁc isodense band)23, a later study by the
same group demonstrated ~ 20% (statistically signiﬁcant)
reduction of NFL transcript in the schizophrenic dorso-
lateral prefrontal cortex (layer V)69. Many recent unbiased
proteomic studies also demonstrated consistent and sig-
niﬁcant reduction of NFL subunits in brain regions
essential for the cognitive and behavior functions affected
in schizophrenia (Supplementary Table S2). The fact that
NFL, NFM and NFH genes map to chromosomal regions
(8p21, 8p22, and 22q12, respectively) that are strongly
implicated in schizophrenia raises the possibility of an
involvement of NF proteins in this disease70,71. NFL
showed consistently reduced expression in three brain
regions (anterior cingulate gyrus, motor cortex, and
Fig. 5 Model of NMDAR binding to NFL. On the basis of collective ﬁndings on NF scaffolding functions and our GluN1 data on NFL deletion mice,
we propose a model by which NFL acts in synaptic terminals to bind NMDAR on postsynaptic terminals to stabilize the level by protecting against
ubiquitination of GluN1. In NFL+/+, GluN1 subunits are physiologically ubiquitinated and degraded as indicated by thin arrows; in NFL−/−, greater
ubiquitination and degradation of GluN1 leading to reduced NMDAR function as indicated by thick arrows
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thalamus) following gene expression analysis of post-
mortem brain tissue of autism patients72. NFL also
showed genetic association with autism in Caucation
families72. Our ﬁndings are consistent with a model (Fig.
5) in which NFL within a synaptic cytoskeletal lattice
binds to the GluN1 receptor and maintains its levels on
the postsynaptic surface by preventing its ubiquitination
and turnover. Lowered levels of NFL, a substrate for
calpains73, proteasome74, and autophagy75 (Rao et al. to be
submitted), result in greater ubiquitination and degrada-
tion of GluN1 receptors and possibly disruption of key
PP1-CamKII interactions with the NMDAR leading to
hypofunction of NMDAR signaling. Recent studies of
synaptic scaffold proteins suggest that they may form
large protein networks and play a major role in synaptic
function including the trafﬁcking, anchoring, clustering,
and stability of glutamate receptors76. Our present results
together with previous ﬁndings77–79 document the likely
interactions of NFL, and NF proteins in general, in the
scaffold of networked proteins (Supplementary Figure S1)
and in the dysfunction of the synaptic scaffold proteins as
a molecular basis for severe neuropsychiatric disorders
(Supplementary Table S1).
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